HTG Molecular Diagnostics Inc (HTGM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HTG Molecular Diagnostics Inc (HTGM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11497
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also offers endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support and ingenuity IPA data analysis services, among others. The company serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG is headquartered in Tucson, Arizona, the US.

HTG Molecular Diagnostics Inc (HTGM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 9
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 11
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 12
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 13
Partnerships 14
HTG Molecular Diagnostics Enters into Partnership Agreement with Oncologie 14
HTG Molecular Diagnostics and Firalis Enter into Agreement 15
HTG Molecular Diagnostics Inc – Key Competitors 16
HTG Molecular Diagnostics Inc – Key Employees 17
HTG Molecular Diagnostics Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Financial Announcements 19
Aug 07, 2018: HTG Molecular Diagnostics reports second quarter 2018 results 19
May 10, 2018: HTG Molecular Diagnostics Reports First Quarter 2018 Results 20
Mar 22, 2018: HTG Molecular Diagnostics Announces Fourth Quarter And Full Year 2017 Results 21
Jan 04, 2018: HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance 22
Nov 07, 2017: HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings 23
Aug 08, 2017: HTG Molecular Diagnostics Reports Second Quarter 2017 Results 24
May 15, 2017: HTG Molecular Diagnostics Reports First Quarter 2017 Results 25
Mar 23, 2017: HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results 26
Corporate Communications 27
Oct 31, 2018: HTG Molecular appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President 27
Aug 16, 2018: HTG Molecular appoints Michelle R. Griffin to its board of directors 28
Apr 16, 2018: HTG Promotes John Lubniewski to President and Chief Operating Officer 29
Mar 07, 2017: HTG Molecular Diagnostics Appoints New Chair of the Board of Directors 30
Legal and Regulatory 31
Sep 18, 2017: HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 9
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 11
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 12
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 13
HTG Molecular Diagnostics Enters into Partnership Agreement with Oncologie 14
HTG Molecular Diagnostics and Firalis Enter into Agreement 15
HTG Molecular Diagnostics Inc, Key Competitors 16
HTG Molecular Diagnostics Inc, Key Employees 17

List of Figures
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[HTG Molecular Diagnostics Inc (HTGM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caixa Economica Federal:企業の戦略・SWOT・財務分析
    Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • U.S. Department of Veterans Affairs-製薬・医療分野:企業M&A・提携分析
    Summary U.S. Department of Veterans Affairs (DVA) is a healthcare organization that provides benefit management and veteran services. The organization provides general benefits information, disability compensation, pension, GI bill, vocational rehabilitation and employment, vet success, educational …
  • Beijer Ref Ab:企業のM&A・事業提携・投資動向
    Beijer Ref Ab - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beijer Ref Ab Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • B&G Foods, Inc.:企業のM&A・事業提携・投資動向
    B&G Foods, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's B&G Foods, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Hybrigenics SA (ALHYG):企業の財務・戦略的SWOT分析
    Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Analytica Limited (ALT):医療機器:M&Aディール及び事業提携情報
    Summary Analytica Limited (Analytica) is a specialty diagnostic and laboratory equipment company. It designs, develops and supplies Class I and II medical devices. The company provides women’s health systems and intravenous (IV) medication delivery systems. Its major products include PeriCoach e-hea …
  • Synthetic Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Synthetic Genomics Inc (Synthetic Genomics) is a provider of synthetic biology and synthetic genomics solutions. The company offers DNA synthesis services, instrumentation, reagents, and bioinformatics services and software packages. It offers solutions in genomics research, bioproduction, a …
  • Zest Dental Solutions:医療機器:M&Aディール及び事業提携情報
    Summary Zest Dental Solutions (Zest Dental), formerly ZEST Anchors LLC is a medical device manufacturing company that manufactures, develops, and distributes dental solutions for the treatment of edentulous patients. The company’s products include dental removal tool, attachment processing materials …
  • Underwriters Laboratories Inc.:企業のM&A・事業提携・投資動向
    Underwriters Laboratories Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Underwriters Laboratories Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Sodexo Inc:企業の戦略的SWOT分析
    Sodexo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • RentPath LLC:企業の戦略的SWOT分析
    RentPath LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Prologis, Inc.:企業のM&A・事業提携・投資動向
    Prologis, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Prologis, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Ellex Medical Lasers Limited (ELX):企業の財務・戦略的SWOT分析
    Ellex Medical Lasers Limited (ELX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • United Spirits Ltd:企業の戦略・SWOT・財務情報
    United Spirits Ltd - Strategy, SWOT and Corporate Finance Report Summary United Spirits Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China Gas Holdings Ltd (384):電力:M&Aディール及び事業提携情報
    Summary China Gas Holdings Ltd (CGHL) is a gas operator and service provider. The company offers piped natural gas, compressed natural gas, liquid petroleum gas and liquefied natural gas. Its activities include construction and operation of gas stations, gas pipeline infrastructure facilities, gas t …
  • Thaivivat Insurance Public Company Limited:企業の戦略・SWOT・財務分析
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Southern Maryland Electric Cooperative Inc:発電所・企業SWOT分析
    Southern Maryland Electric Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, infor …
  • Jupiter Telecommunications Co Ltd:企業の戦略的SWOT分析
    Jupiter Telecommunications Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Zynex Inc (ZYXI):医療機器:M&Aディール及び事業提携情報
    Summary Zynex Inc (Zynex), formerly Zynex Medical Inc is a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, tra …
  • Aldi Einkauf GmbH & Co oHG:戦略・SWOT・企業財務分析
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆